Table 1.
CSDH cohort demographic, reason for antithrombotic therapy, and characteristics of the chronic subdural haematoma. Categorical Variables Represented as n (%), Continuous Variables Represented as Mean (± Standard Deviation)
| Demographics summary table | |
|---|---|
| Total number of patients | 2675 |
| Average age, years ± SD | 78.5 ± 11.5 |
| Male patients (%) | 1799 (67.3) |
| Female patients (%) | 876 (32.7) |
| Number of patients on antithrombotic therapy | 905 (33.8) |
| Reason for antithrombotic therapy | Number of patients with condition (%) |
| Ischaemic Heart Disease | 362 (13.5) |
| Cardiac rhythm disorder | 545 (20.4) |
| Cardiac valvular disease | 110 (4.11) |
| Peripheral vascular disease | 97 (3.6) |
| Type of antithrombotic medication | Number of patients on antithrombotic medication (%) |
| Warfarin | 298 (11.1) |
| DOAC | 203 (7.6) |
| Aspirin | 202 (7.55) |
| Antiplatelet | 148 (5.5) |
| LMWH | 54 (2.02) |
| CSDH Characteristics | Number of patients with condition (%) |
| Glasgow Coma Score (GCS) | |
| GCS 15 (%) | 1784 (66.7) |
| GCS 14 (%) | 545 (20.4) |
| GCS 13 (%) | 165 (6.2) |
| GCS <13 (%) | 181 (6.8) |
| CSDH Size | |
| Small (%) | 1101 (41.2) |
| Moderate (%) | 810 (30.3) |
| Large (%) | 764 (28.6) |
| Midline shift (%) | 775 (28.97) |